Havlucu Y, Kursat S, Ekmekci C, Celik P, Serter S, Bayturan O, Dinc G
Department of Chest Disease, Dortyol State Hospital, Hatay, Turkey.
Respiration. 2007;74(5):503-10. doi: 10.1159/000102953. Epub 2007 May 15.
Many etiologies causing pulmonary hypertension (PH) have been reported, and one of the background disease seen with patients with PH is chronic renal failure (CRF); however, the pathogenesis of PH in this group of patients is not explained satisfactorily.
The aims of this study were to evaluate the incidence of unexplained PH among patients with CRF and to suggest possible etiologic factors.
Two hundred and eleven patients with CRF were evaluated and the ones who have comorbid conditions that cause PH were excluded. Pulmonary arterial pressure (PAP) and cardiac functions were evaluated by Doppler echocardiography. Arteriovenous fistula (AVF) flow was measured by Doppler sonography. The patients were followed for at least 6 months.
Forty-eight CRF patients (20 males, 28 females) were included: 23 were predialysis patients, and 25 patients received hemodialysis via AVF. Patients were followed for 7.5 +/- 1.01 months. Systolic PAP >35 mm Hg was found in 56% (14/25) of patients receiving hemodialysis (36.8 +/- 10.7 mm Hg) and in 39.1% (9/23) of predialysis patients (29.5 +/- 9.5 mm Hg). The parathyroid hormone level, cardiac output values and CRF duration were found to be increased in patients with elevated systolic PAP (p < 0.05). AVF flow and AVF duration were positively correlated with systolic PAP in patients receiving hemodialysis (p < 0.05). There was a negative correlation between systolic PAP and residual urine volume (p < 0.05). AVF compression in hemodialysis patients decreased systolic PAP from 36.8 +/- 10.7 to 32.8 +/- 10.5 mm Hg. Systolic PAP values were increased at the end of the study in the predialysis group, whereas they were decreased at the end of the follow-up in the hemodialysis group (36.9 +/- 10.5 and 32.04 +/- 10.5 mm Hg, respectively).
This study demonstrates a high incidence of PH among patients with CRF. CRF duration, AVF flow, parathyroid hormone level and cardiac output may be involved in the pathogenesis of PH. The effective hemodialysis and dry weight reduction decreased systolic PAP values.
已报道了许多导致肺动脉高压(PH)的病因,慢性肾衰竭(CRF)是PH患者中常见的基础疾病之一;然而,这组患者中PH的发病机制尚未得到令人满意的解释。
本研究旨在评估CRF患者中不明原因PH的发生率,并提出可能的病因。
对211例CRF患者进行评估,排除合并有导致PH的疾病的患者。通过多普勒超声心动图评估肺动脉压(PAP)和心功能。通过多普勒超声测量动静脉瘘(AVF)血流量。对患者进行至少6个月的随访。
纳入48例CRF患者(男性20例,女性28例):23例为透析前患者,25例患者通过AVF进行血液透析。患者随访7.5±1.01个月。接受血液透析的患者中56%(14/25)收缩期PAP>35 mmHg(36.8±10.7 mmHg),透析前患者中39.1%(9/23)收缩期PAP>35 mmHg(29.5±9.5 mmHg)。收缩期PAP升高的患者甲状旁腺激素水平、心输出量值和CRF病程增加(p<0.05)。接受血液透析的患者中,AVF血流量和AVF使用时间与收缩期PAP呈正相关(p<0.05)。收缩期PAP与残余尿量呈负相关(p<0.05)。血液透析患者的AVF压迫使收缩期PAP从36.8±10.7 mmHg降至32.8±10.5 mmHg。透析前组研究结束时收缩期PAP值升高,而血液透析组随访结束时收缩期PAP值降低(分别为36.9±10.5 mmHg和32.04±10.5 mmHg)。
本研究表明CRF患者中PH的发生率较高。CRF病程、AVF血流量、甲状旁腺激素水平和心输出量可能参与PH的发病机制。有效的血液透析和减轻干体重可降低收缩期PAP值。